Cargando…
Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure
In cancer cells, the oncogenic mutant p53 (mtp53) protein is present at high levels and gain-of-function (GOF) activities with more expression of mtp53 proteins contribute to tumor growth and metastasis. Robust analytical approaches that probe the degree of metastasis of cancer cells in connection w...
Autores principales: | Shi, Menglu, Shtraizent, Nataly, Polotskaia, Alla, Bargonetti, Jill, Matsui, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060997/ https://www.ncbi.nlm.nih.gov/pubmed/24937470 http://dx.doi.org/10.1371/journal.pone.0099351 |
Ejemplares similares
-
Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient
por: Shtraizent, Nataly, et al.
Publicado: (2015) -
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death
por: Rosso, Melissa, et al.
Publicado: (2015) -
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2011) -
Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2012) -
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
por: Qiu, Wei-Gang, et al.
Publicado: (2017)